Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 3
Submit an article Journal homepage
982
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Comparison of the antidiabetic effects of linagliptin among groups with a normal renal function and a mild or severe renal impairment – retrospective observation study of Japanese patients with type 2 diabetes mellitus

Hiroyuki ItoEdogawa Hospital, Department of Diabetes, Metabolism and Kidney Disease, 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan+81 3 3673 1221; +81 3 3673 1229; [email protected]
, MD PhD,
Mariko AbeEdogawa Hospital, Department of Diabetes, Metabolism and Kidney Disease, 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan+81 3 3673 1221; +81 3 3673 1229; [email protected]
, MD,
Shinichi AntokuEdogawa Hospital, Department of Diabetes, Metabolism and Kidney Disease, 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan+81 3 3673 1221; +81 3 3673 1229; [email protected]
, MD,
Takashi OmotoEdogawa Hospital, Department of Diabetes, Metabolism and Kidney Disease, 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan+81 3 3673 1221; +81 3 3673 1229; [email protected]
, MD,
Masahiro ShinozakiEdogawa Hospital, Department of Diabetes, Metabolism and Kidney Disease, 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan+81 3 3673 1221; +81 3 3673 1229; [email protected]
, MD,
Shinya NishioEdogawa Hospital, Department of Diabetes, Metabolism and Kidney Disease, 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan+81 3 3673 1221; +81 3 3673 1229; [email protected]
, MD,
Mizuo MifuneEdogawa Hospital, Department of Diabetes, Metabolism and Kidney Disease, 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan+81 3 3673 1221; +81 3 3673 1229; [email protected]
, MD PhD &
Michiko ToganeEdogawa Hospital, Department of Diabetes, Metabolism and Kidney Disease, 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo, 133-0052, Japan+81 3 3673 1221; +81 3 3673 1229; [email protected]
, MD PhD show all
Pages 289-296 | Published online: 22 Dec 2014

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Hiroyuki Ito, Suzuko Matsumoto, Takuma Izutsu, Eiji Kusano, Shinya Nishio, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane, Shigenori Ando & Emiko Tsugami. (2019) Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes. Diabetes, Metabolic Syndrome and Obesity 12, pages 1783-1794.
Read now
Hiroyuki Ito, Masahiro Shinozaki, Shinya Nishio & Mariko Abe. (2016) SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan. Expert Opinion on Pharmacotherapy 17:15, pages 2073-2084.
Read now
Chu-qing Cao, Yu-fei Xiang & Zhi-guang Zhou. (2015) The clinical application of linagliptin in Asians. Therapeutics and Clinical Risk Management 11, pages 1409-1419.
Read now
Shinya Nishio, Mariko Abe & Hiroyuki Ito. (2015) Anagliptin in the treatment of type 2 diabetes: safety, efficacy, and patient acceptability. Diabetes, Metabolic Syndrome and Obesity 8, pages 163-171.
Read now

Articles from other publishers (4)

Mozhgan Karimifar, Jamileh Afsar, Massoud Amini, Firouzeh Moeinzadeh, Awat Feizi & Ashraf Aminorroaya. (2023) The effect of linagliptin on microalbuminuria in patients with diabetic nephropathy: a randomized, double blinded clinical trial. Scientific Reports 13:1.
Crossref
Hiroyuki Ito, Suzuko Matsumoto, Takuma Izutsu, Eiji Kusano, Jiro Kondo, Hideyuki Inoue, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori & Michiko Togane. (2021) Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation. PLOS ONE 16:3, pages e0248577.
Crossref
Hiroyuki Ito, Shigenori Ando, Emiko Tsugami, Rie Araki, Eiji Kusano, Suzuko Matsumoto, Kosuke Uemura, Shinya Nishio, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori & Michiko Togane. (2019) Changes in medication adherence and unused drugs after switching from daily dipeptidyl peptidase-4 inhibitors to once-weekly trelagliptin in patients with type 2 diabetes. Diabetes Research and Clinical Practice 153, pages 41-48.
Crossref
Antonio Ceriello & Nobuya Inagaki. (2017) Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations. Journal of Diabetes Investigation 8:1, pages 19-28.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.